Talk:Oncogenic osteomalacia
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | The contents of the Phosphaturic mesenchymal tumor page were merged into Oncogenic osteomalacia on 14 May 2017. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
Merge Phosphaturic mesenchymal tumor to here?
[edit]- yes as nom Wiki CRUK John (talk) 13:11, 11 June 2014 (UTC)
Done Klbrain (talk) 21:52, 14 May 2017 (UTC)
Add new treatment?
[edit]I'm too new to add this myself, but could an additional treatment paragraph be added, along the lines of: On June 18, 2020, the U.S. FDA approved a new treatment, Crysvita (burosumab-twza), for tumor-induced osteomalacia. https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-disease-causes-low-phosphate-blood-levels-bone-softening
Here's the Wikipedia page for Crysvita/burosumab: https://en.wikipedia.org/wiki/Burosumab AuthorGinJones (talk) 23:12, 19 October 2020 (UTC)
Can we rename the page tumour induced osteomalacia
[edit]This is the more commonly used name I have found 2A04:4A43:8A7F:F595:60A3:7DFA:1B25:2585 (talk) 11:20, 10 July 2024 (UTC)